Your browser doesn't support javascript.
loading
Vaccine-associated attenuation of subjective severity among outpatients with influenza.
Chung, Jessie R; Kim, Sara S; Flannery, Brendan; Smith, Michael E; Dunnigan, Kayan; Raiyani, Chandni; Murthy, Kempapura; Gaglani, Manjusha; Jackson, Michael L; Jackson, Lisa A; Bear, Todd; Moehling Geffel, Krissy; Nowalk, Mary Patricia; Zimmerman, Richard K; Martin, Emily T; Lamerato, Lois; McLean, Huong Q; King, Jennifer P; Belongia, Edward A; Thompson, Mark G; Patel, Manish.
Affiliation
  • Chung JR; U.S. Centers for Disease Control and Prevention, Influenza Division, Atlanta, GA, United States. Electronic address: jchung@cdc.gov.
  • Kim SS; U.S. Centers for Disease Control and Prevention, Influenza Division, Atlanta, GA, United States.
  • Flannery B; U.S. Centers for Disease Control and Prevention, Influenza Division, Atlanta, GA, United States.
  • Smith ME; Baylor Scott & White Health, Temple, TX, United States.
  • Dunnigan K; Baylor Scott & White Health, Temple, TX, United States.
  • Raiyani C; Baylor Scott & White Health, Temple, TX, United States.
  • Murthy K; Baylor Scott & White Health, Temple, TX, United States.
  • Gaglani M; Baylor Scott & White Health, Temple, TX, United States; Texas A&M University College of Medicine, Temple, TX, United States.
  • Jackson ML; Kaiser Permanente Washington Health Research Institute, Seattle, WA, United States.
  • Jackson LA; Kaiser Permanente Washington Health Research Institute, Seattle, WA, United States.
  • Bear T; University of Pittsburgh, United States.
  • Moehling Geffel K; University of Pittsburgh, United States.
  • Nowalk MP; University of Pittsburgh, United States.
  • Zimmerman RK; University of Pittsburgh, United States.
  • Martin ET; University of Michigan School of Public Health, Ann Arbor, MI, United States.
  • Lamerato L; Henry Ford Health System, Detroit, MI, United States.
  • McLean HQ; Marshfield Clinic Research Institute, Marshfield, WI, United States.
  • King JP; Marshfield Clinic Research Institute, Marshfield, WI, United States.
  • Belongia EA; Marshfield Clinic Research Institute, Marshfield, WI, United States.
  • Thompson MG; U.S. Centers for Disease Control and Prevention, Influenza Division, Atlanta, GA, United States.
  • Patel M; U.S. Centers for Disease Control and Prevention, Influenza Division, Atlanta, GA, United States.
Vaccine ; 40(32): 4322-4327, 2022 07 30.
Article in En | MEDLINE | ID: mdl-35710506
Influenza vaccines can mitigate illness severity, including reduced risk of ICU admission and death, in people with breakthrough infection. Less is known about vaccine attenuation of mild/moderate influenza illness. We compared subjective severity scores in vaccinated and unvaccinated persons with medically attended illness and laboratory-confirmed influenza. Participants were prospectively recruited when presenting for care at five US sites over nine seasons. Participants aged ≥ 16 years completed the EQ-5D-5L visual analog scale (VAS) at enrollment. After controlling for potential confounders in a multivariable model, including age and general health status, VAS scores were significantly higher among 2,830 vaccinated participants compared with 3,459 unvaccinated participants, indicating vaccinated participants felt better at the time of presentation for care. No differences in VAS scores were observed by the type of vaccine received among persons aged ≥ 65 years. Our findings suggest vaccine-associated attenuation of milder influenza illness is possible.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Influenza Vaccines / Influenza, Human Type of study: Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Humans Language: En Journal: Vaccine Year: 2022 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Influenza Vaccines / Influenza, Human Type of study: Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Humans Language: En Journal: Vaccine Year: 2022 Document type: Article Country of publication: